New cancer drug CT7439 enters human testing
Disease control
Recruiting now
This early-phase study tests a new drug called CT7439, alone or with other cancer treatments, in about 50 adults with solid tumors that have not responded to standard therapy. The main goal is to check safety and find the best dose. Researchers will also watch for any tumor shrin…
Phase: PHASE1, PHASE2 • Sponsor: Carrick Therapeutics Limited • Aim: Disease control
Last updated May 15, 2026 11:57 UTC